Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

04/02/2022 08:00

Feb 4 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            335 mln             160 mln                    
                (+109.4 pct)         (-0.9 pct)                   
  Operating       loss 1.71           loss 1.27                   
  Recurring       loss 1.72           loss 1.26                   
  Net             loss 2.14           loss 1.18                   
  EPS          loss 11.52 yen       loss 6.71 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T